Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...

When Ruth Nankanja Mukiibi, founding director of the Sickle Cell Association of Uganda, had her first pregnancy two decades ago, she defied both medical convention and her doctor's stern warnings. “A ...

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.

Agios maintains a robust balance sheet and is positioned for significant growth if regulatory approvals and market expansion ...

The Boozer twins have an older brother, Carmani Boozer. After playing baseball at Monisgnor Edward Pace High School in Miami, ...

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...

Vitalant has expanded mobile blood drives and outreach efforts, while the National Association of Hispanic Nurses encourages members to lead by example and educate their communiti ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Thousands of Californians live with sickle cell disease, a painful blood disorder. But new treatments, including a promising form of gene therapy, are offering hope to ...